The company attributed the drop to expected revenue declines in client services and private label demineralized bone matrix.
Read the release on Osteotech’s third-quarter revenues.
Osteotech experienced a 4.5% decline in revenue in the third quarter compared with the same period last year, according to a release from Osteotech.
The company attributed the drop to expected revenue declines in client services and private label demineralized bone matrix.
Read the release on Osteotech’s third-quarter revenues.